Indigo Diabetes N.V.
PrivateLast Round
Accelerator
Jun 5, 2025
Total Funding Raised
$55.52M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Indigo Diabetes N.V. is a medical technology company that develops implantable continuous multi-metabolite monitoring (CMM) sensors for the management of chronic diseases such as diabetes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Clinical Trials
Business Model
B2B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Indigo Diabetes N.V. Comparables
Compare Indigo Diabetes N.V. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlySens Incorporated | 81% | |
| GlucoModicum | 80% | |
| Laxmi Therapeutic Devices | 79% |
Indigo Diabetes N.V. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 5, 2025 | ||||
| Grant | Sep 7, 2021 | ||||
| Series B | Jul 27, 2020 | ||||
| Grant | Jul 1, 2018 | ||||
| Series A | Dec 19, 2016 |
Key People
Founding team and executive leadership
Indigo Diabetes N.V. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ackermans & van Haaren | Series B |
| Fund+ | Series B |
| MedTech Innovator | Accelerator |
| imec.xpand | Series B |
| PMV | Series B, Series A |
| Qbic II | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 351% MoM, reaching 3.5K.
- Jan 21, 2026
Monthly visitors increased 264% MoM, reaching 2.4K.
Indigo Diabetes N.V. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Indigo Diabetes N.V.'s valuation, stock price, and market status.
Is Indigo Diabetes N.V. a public or private company?
Indigo Diabetes N.V. is a private company.
What is the current stock price of Indigo Diabetes N.V.?
Indigo Diabetes N.V. is a private company with no public stock price. No recent secondary market data is available.
How much is Indigo Diabetes N.V. worth (valuation)?
Valuation information for Indigo Diabetes N.V. is not publicly available.
Can I buy Indigo Diabetes N.V. stock?
Indigo Diabetes N.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Indigo Diabetes N.V.'s last funding round?
Indigo Diabetes N.V.'s most recent funding round was Accelerator on June 5, 2025.
Who are the main investors in Indigo Diabetes N.V.?
Key investors in Indigo Diabetes N.V. include Fund+, PMV.
Will Indigo Diabetes N.V. IPO soon?
No public IPO plans have been announced for Indigo Diabetes N.V..
How can I track Indigo Diabetes N.V. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Indigo Diabetes N.V.'s secondary market activity and sign up for updates.